Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)
China · Delayed Price · Currency is CNY 3.790
+0.040 (1.07%)
Aug 1, 2025, 2:45 PM CST
SHE:002390 Revenue
Guizhou Xinbang Pharmaceutical had revenue of 1.44B CNY in the quarter ending March 31, 2025, a decrease of -8.93%. This brings the company's revenue in the last twelve months to 5.89B, down -8.50% year-over-year. In the year 2024, Guizhou Xinbang Pharmaceutical had annual revenue of 6.03B, down -6.63%.
Revenue (ttm)
5.89B
Revenue Growth
-8.50%
P/S Ratio
1.22
Revenue / Employee
1.16M
Employees
5,059
Market Cap
7.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.03B | -428.58M | -6.63% |
| Dec 31, 2023 | 6.46B | 110.82M | 1.75% |
| Jan 1, 2023 | 6.35B | -121.84M | -1.88% |
| Jan 1, 2022 | 6.47B | 626.24M | 10.71% |
| Dec 31, 2020 | 5.85B | -809.44M | -12.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 41.48B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |